 Image via Biotricity.com Thursday, August 26, 2021, Biotricity, Inc. NASDAQ: BTCY uplisted to Nasdaq after raising 15 million to fuel its continued growth and expansion. Biotricity is a cardiac monitoring and data management company in the medtech arena that provides active, high-quality, real-time 247 monitoring and high-end clinical diagnostics through its Bioflux, flagship device. 